These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 8391259)
41. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Ohmichi M; Pang L; Ribon V; Gazit A; Levitzki A; Saltiel AR Biochemistry; 1993 May; 32(17):4650-8. PubMed ID: 7683492 [TBL] [Abstract][Full Text] [Related]
42. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Durante W; Kroll MH; Vanhoutte PM; Schafer AI Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423 [TBL] [Abstract][Full Text] [Related]
43. Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. Navran SS; Romstedt K; Chang J; Miller DD; Feller DR; Huzoor-Akbar Thromb Res; 1984 Mar; 33(5):499-510. PubMed ID: 6372157 [TBL] [Abstract][Full Text] [Related]
44. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover. Ozaki Y; Yatomi Y; Jinnai Y; Kume S Biochem Pharmacol; 1993 Aug; 46(3):395-403. PubMed ID: 8394081 [TBL] [Abstract][Full Text] [Related]
45. The effects of lithium on platelet phosphoinositide metabolism. Huang EM; Detwiler TC Biochem J; 1986 Jun; 236(3):895-901. PubMed ID: 3024627 [TBL] [Abstract][Full Text] [Related]
46. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets. Nunn DL; Watson SP Biochem J; 1987 May; 243(3):809-13. PubMed ID: 2821994 [TBL] [Abstract][Full Text] [Related]
47. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2. Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687 [TBL] [Abstract][Full Text] [Related]
48. Phosphoinositide metabolism triggered by wheat germ agglutinin in human platelets. Yatomi Y; Ozaki Y; Kume S Int J Hematol; 1995 Oct; 62(3):163-73. PubMed ID: 8589361 [TBL] [Abstract][Full Text] [Related]
49. Tyrphostin 23 blocks phosphorylation of p42 but not p38 mitogen-activated protein kinase by zooxanthellatoxin-A. Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y Eur J Pharmacol; 1997 Jan; 319(2-3):375-8. PubMed ID: 9042614 [TBL] [Abstract][Full Text] [Related]
51. Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets. Polascik T; Godfrey PP; Watson SP Biochem J; 1987 May; 243(3):815-9. PubMed ID: 3663101 [TBL] [Abstract][Full Text] [Related]
52. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Pumiglia KM; Lau LF; Huang CK; Burroughs S; Feinstein MB Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):441-9. PubMed ID: 1530576 [TBL] [Abstract][Full Text] [Related]
53. Effects of chlorpromazine on phosphatidylinositol turnover following thrombin stimulation of human platelets. Wakatabe H; Tsukahara T; Ishigooka J; Miura S Biol Psychiatry; 1991 May; 29(10):965-78. PubMed ID: 1905965 [TBL] [Abstract][Full Text] [Related]
54. Serotonin release and phosphoinositide breakdown in thrombin-induced activation of human platelets. Marche P; Rendu F; Maclouf J; Girard A; Levy-Toledano S J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S18-9. PubMed ID: 2412047 [TBL] [Abstract][Full Text] [Related]
55. Inositol lipids, phosphatidate and diacylglycerol share stearoylarachidonoylglycerol as a common backbone in thrombin-stimulated human platelets. Mauco G; Dangelmaier CA; Smith JB Biochem J; 1984 Dec; 224(3):933-40. PubMed ID: 6525180 [TBL] [Abstract][Full Text] [Related]
56. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity. Dadi H; Ke S; Roifman CM Blood; 1994 Sep; 84(5):1579-86. PubMed ID: 7520779 [TBL] [Abstract][Full Text] [Related]
57. Thrombin induces a biphasic 1,2-diacylglycerol production in human platelets. Nakashima S; Suganuma A; Matsui A; Nozawa Y Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):355-61. PubMed ID: 1902664 [TBL] [Abstract][Full Text] [Related]
58. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. Bryckaert MC; Rendu F; Tobelem G; Caen J Biochem Biophys Res Commun; 1986 Feb; 135(1):52-7. PubMed ID: 3006686 [TBL] [Abstract][Full Text] [Related]
59. Phosphatidylinositol 3,4,5-trisphosphate is formed from phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. Carter AN; Huang R; Sorisky A; Downes CP; Rittenhouse SE Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):415-20. PubMed ID: 8042983 [TBL] [Abstract][Full Text] [Related]
60. The role of the phosphatidylinositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli alpha-haemolysin, thrombin and fluoride. König B; König W Immunology; 1993 Dec; 80(4):633-9. PubMed ID: 8307614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]